Ricolinostat
Showing 1 - 13 of 13
Peripheral Nervous System Diseases Trial in Changchun (ricolinostat)
Recruiting
- Peripheral Nervous System Diseases
- ricolinostat
-
Changchun, ChinaBethune First Hospital Of Jilin University
Mar 1, 2022
Peripheral Nervous System Diseases Trial (Ricolinostat)
Not yet recruiting
- Peripheral Nervous System Diseases
- Ricolinostat
- (no location specified)
Feb 6, 2022
Multiple Myeloma Trial in Worldwide (ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone)
Active, not recruiting
- Multiple Myeloma
- ACY-1215 (Ricolinostat) in combination with pomalidomide and dexamethasone
-
Atlanta, Georgia
- +25 more
Aug 31, 2022
Recurrent Chronic Lymphoid Leukemia Trial in Boston (ACY-1215, Ibrutinib, Idelalisib)
Active, not recruiting
- Recurrent Chronic Lymphoid Leukemia
- ACY-1215
- +2 more
-
Boston, MassachusettsDana Farber Cancer Institute
Dec 19, 2022
Metastatic Breast Cancer, Breast Carcinoma Trial in New York (ACY-1215, Nab-paclitaxel)
Completed
- Metastatic Breast Cancer
- Breast Carcinoma
-
New York, New YorkColumbia Irving University Medical Center
Jan 5, 2021
Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Carcinoma Trial in Boston (Paclitaxel, Ricolinostat, Bevacizumab)
Multiple Myeloma Trial in Dallas, San Antonio, Salt Lake City (ACY-1215 in combination with pomalidomide and dexamethasone)
Completed
- Multiple Myeloma
- ACY-1215 in combination with pomalidomide and dexamethasone
-
Dallas, Texas
- +2 more
Nov 20, 2019
Nab-paclitaxel in Combination With Gemcitabine in Route Clinical
Terminated
- Pancreatic Neoplasms
-
Heerenveen, Friesland, Netherlands
- +17 more
Sep 12, 2019
Non-Resectable Cholangiocarcinoma, Recurrent Cholangiocarcinoma, Stage III Extrahepatic Bile Duct Cancer Trial in Scottsdale,
Withdrawn
- Non-Resectable Cholangiocarcinoma
- +12 more
- Cisplatin
- +4 more
-
Scottsdale, Arizona
- +2 more
May 25, 2017
Healthy Trial in Madison (ACY-1215)
Completed
- Healthy
-
Madison, WisconsinCovance Clinical Research Unit Incorporated
Sep 10, 2014